Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dawn Sim

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Clinical Ophthalmology (Auckland, N.Z.)|March 13, 2020
Two Year Visual Acuity and Structural Outcomes in Patients with Diabetic Macular Oedema Treated with Intravitreal Aflibercept - A Retrospective Cohort StudyChristoph Kern, Johannes Schiefelbein, Dun Jack Fu, et al.
Acta Ophthalmologica|July 10, 2019
Comparing diabetic retinopathy lesions in scanning laser ophthalmoscopy and colour fundus photographyAllan Zhifa Nghiem, Paul Nderitu, Marko Lukic, et al.
Eye (London, England)|December 10, 2024
Visual and anatomical failure of anti-VEGF therapy for retinal vascular diseases: a survival analysis of real-world dataDun Jack Fu, Amit V Mishra, Chrystie Quek, et al.
Journal of Clinical Medicine|June 28, 2023
Visual and Anatomical Outcomes of a Single Intravitreal Dexamethasone in Diabetic Macular Edema: An 8 Year Real-World StudyLivia Faes, Amit V Mishra, Veronika Lipkova, et al.
Ophthalmology. Retina|February 21, 2021
Patterns and Characteristics of a Clinical Implementation of a Self-Monitoring Program for Retina Diseases during the COVID-19 PandemicKelvin Yi Chong Teo, Lucas M Bachmann, Dawn Sim, et al.
The British Journal of Ophthalmology|April 1, 2016
UK Neovascular Age-Related Macular Degeneration Database. Report 6: time to retreatment after a pause in therapy. Outcomes from 92 976 intravitreal ranibizumab injectionsKrishnappa C Madhusudhana, Aaron Y Lee, Pearse A Keane, et al.
European Journal of Ophthalmology|February 28, 2019
Intravitreal aflibercept for diabetic macular oedema: Moorfields' real-world 12-month visual acuity and anatomical outcomesMarko Lukic, Gwyn Williams, Zaid Shalchi, et al.
Eye (London, England)|July 24, 2020
Correction: Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working GroupWinfried M Amoaku, Faruque Ghanchi, Clare Bailey, et al.
Eye (London, England)|June 7, 2020
Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working GroupWinfried M Amoaku, Faruque Ghanchi, Clare Bailey, et al.
The Lancet. Digital Health|December 16, 2020
Automated deep learning design for medical image classification by health-care professionals with no coding experience: a feasibility studyLivia Faes, Siegfried K Wagner, Dun Jack Fu, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Clinical Ophthalmology (Auckland, N.Z.)|March 13, 2020
Two Year Visual Acuity and Structural Outcomes in Patients with Diabetic Macular Oedema Treated with Intravitreal Aflibercept - A Retrospective Cohort StudyChristoph Kern, Johannes Schiefelbein, Dun Jack Fu, et al.
Acta Ophthalmologica|July 10, 2019
Comparing diabetic retinopathy lesions in scanning laser ophthalmoscopy and colour fundus photographyAllan Zhifa Nghiem, Paul Nderitu, Marko Lukic, et al.
Eye (London, England)|December 10, 2024
Visual and anatomical failure of anti-VEGF therapy for retinal vascular diseases: a survival analysis of real-world dataDun Jack Fu, Amit V Mishra, Chrystie Quek, et al.
Journal of Clinical Medicine|June 28, 2023
Visual and Anatomical Outcomes of a Single Intravitreal Dexamethasone in Diabetic Macular Edema: An 8 Year Real-World StudyLivia Faes, Amit V Mishra, Veronika Lipkova, et al.
Ophthalmology. Retina|February 21, 2021
Patterns and Characteristics of a Clinical Implementation of a Self-Monitoring Program for Retina Diseases during the COVID-19 PandemicKelvin Yi Chong Teo, Lucas M Bachmann, Dawn Sim, et al.
The British Journal of Ophthalmology|April 1, 2016
UK Neovascular Age-Related Macular Degeneration Database. Report 6: time to retreatment after a pause in therapy. Outcomes from 92 976 intravitreal ranibizumab injectionsKrishnappa C Madhusudhana, Aaron Y Lee, Pearse A Keane, et al.
European Journal of Ophthalmology|February 28, 2019
Intravitreal aflibercept for diabetic macular oedema: Moorfields' real-world 12-month visual acuity and anatomical outcomesMarko Lukic, Gwyn Williams, Zaid Shalchi, et al.
Eye (London, England)|July 24, 2020
Correction: Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working GroupWinfried M Amoaku, Faruque Ghanchi, Clare Bailey, et al.
Eye (London, England)|June 7, 2020
Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working GroupWinfried M Amoaku, Faruque Ghanchi, Clare Bailey, et al.
The Lancet. Digital Health|December 16, 2020
Automated deep learning design for medical image classification by health-care professionals with no coding experience: a feasibility studyLivia Faes, Siegfried K Wagner, Dun Jack Fu, et al.
Pageof 3